250 mg/5 mL (50 mg/mL) per Single-dose Syringe

Dr.Reddy's - Facility Picture
Business

Dr. Reddy’s Laboratories announces the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market

September 8, 2020 team Comments Off on Dr. Reddy’s Laboratories announces the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. September 7, 2020 – Dr Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch […]